Stephen S. Yoder
2019
In 2019, Stephen S. Yoder earned a total compensation of $1.6M as Chief Executive Officer at Pieris Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $208,575 |
---|---|
Option Awards | $815,670 |
Salary | $515,000 |
Other | $54,353 |
Total | $1,593,598 |
Yoder received $815.7K in option awards, accounting for 51% of the total pay in 2019.
Yoder also received $208.6K in non-equity incentive plan, $515K in salary and $54.4K in other compensation.
Rankings
In 2019, Stephen S. Yoder's compensation ranked 7,035th out of 13,971 executives tracked by ExecPay. In other words, Yoder earned more than 49.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,035 | 50th |
Manufacturing | 2,697 | 53rd |
Chemicals And Allied Products | 992 | 55th |
Drugs | 841 | 55th |
Pharmaceutical Preparations | 619 | 56th |
Yoder's colleagues
We found two more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2019.